This was in agreement with Shekarriz R et al., 2018 [12] who conducted a study on 40 patients with symptomatic MM and found that serum IL-10 levels were increasing with advanced stages of disease and mean serum IL-10 levels in MM patients with stage III were significantly higher than those of stage I and of stage II patients. The gene discussed is IL10; the disease is Miyoshi myopathy.